Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non-Current Debt: 2011-2012

Historic Non-Current Debt for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $1.8 million.

  • Sonoma Pharmaceuticals' Non-Current Debt fell 81.48% to $424,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $424,000, marking a year-over-year decrease of 81.48%. This contributed to the annual value of $1.8 million for FY2012, which is 11.36% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Non-Current Debt of $1.8 million as of FY2012, which was up 11.36% from $1.6 million recorded in FY2011.
  • Sonoma Pharmaceuticals' Non-Current Debt's 5-year high stood at $1.8 million during FY2012, with a 5-year trough of $1.6 million in FY2011.
  • Over the past 2 years, Sonoma Pharmaceuticals' median Non-Current Debt value was $1.7 million (recorded in 2011), while the average stood at $1.7 million.
  • Data for Sonoma Pharmaceuticals' Non-Current Debt shows a peak YoY climbed of 11.36% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Non-Current Debt (Yearly) stood at $1.6 million in 2011, then increased by 11.36% to $1.8 million in 2012.